Works matching DE "IRINOTECAN"
Results: 1749
The War on Pancreatic Cancer: We Are Not There Yet.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Treatment of Metastatic Pancreatic Adenocarcinoma: New Options and Promising Strategies.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Treatment of Metastatic Pancreatic Adenocarcinoma: A Review.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 1, p. 70
- By:
- Publication type:
- Article
Expanding Options for Pancreatic Cancer... So Where Do We Go From Here?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 1, p. 5
- By:
- Publication type:
- Article
Self‐Thermophoretic Nanoparticles Enhance Intestinal Mucus Penetration and Reduce Pathogenic Bacteria Interception in Colorectal Cancer.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 17, p. 1, doi. 10.1002/adfm.202212013
- By:
- Publication type:
- Article
Nanodrug Carrier Based on Poly(Ursolic Acid) with Self‐Anticancer Activity against Colorectal Cancer.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 9, p. 1, doi. 10.1002/adfm.201907857
- By:
- Publication type:
- Article
Biodegradable Fluorescent Nanoparticles for Endoscopic Detection of Colorectal Carcinogenesis.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 51, p. N.PAG, doi. 10.1002/adfm.201904992
- By:
- Publication type:
- Article
Covalent Organic Framework‐Supported Molecularly Dispersed Near‐Infrared Dyes Boost Immunogenic Phototherapy against Tumors.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 46, p. N.PAG, doi. 10.1002/adfm.201902757
- By:
- Publication type:
- Article
Zirconyl Hydrogenphosphate Nanocontainers for Flexible Transport and Release of Lipophilic Cytostatics, Insecticides, and Antibiotics.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 28, p. N.PAG, doi. 10.1002/adfm.201900543
- By:
- Publication type:
- Article
Poly(Ferulic Acid) with an Anticancer Effect as a Drug Nanocarrier for Enhanced Colon Cancer Therapy.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 15, p. N.PAG, doi. 10.1002/adfm.201808646
- By:
- Publication type:
- Article
Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase).
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 1, p. 129, doi. 10.1007/s00228-024-03767-6
- By:
- Publication type:
- Article
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 3, p. 407, doi. 10.1007/s00228-023-03451-1
- By:
- Publication type:
- Article
Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 53, doi. 10.1007/s00228-021-03206-w
- By:
- Publication type:
- Article
Population pharmacokinetic model of irinotecan and its metabolites in patients with metastatic colorectal cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 4, p. 529, doi. 10.1007/s00228-018-02609-6
- By:
- Publication type:
- Article
A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.
- Published in:
- Child's Nervous System, 2022, v. 38, n. 5, p. 919, doi. 10.1007/s00381-022-05479-7
- By:
- Publication type:
- Article
Retrospective comparative study of irinotecan and pegylated liposomal doxorubicin for platinum-resistant or -refractory epithelial ovarian and primary peritoneal carcinoma.
- Published in:
- Archives of Gynecology & Obstetrics, 2014, v. 290, n. 5, p. 979, doi. 10.1007/s00404-014-3268-7
- By:
- Publication type:
- Article
Antiliver and Colorectal Cancer Activity Metabolites of the Fruits of Cinnamomum macrostemon.
- Published in:
- Chemistry of Natural Compounds, 2024, v. 60, n. 2, p. 324, doi. 10.1007/s10600-024-04313-7
- By:
- Publication type:
- Article
Anticolorectal Cancer Activity Metabolites from Michelia compressa.
- Published in:
- Chemistry of Natural Compounds, 2023, v. 59, n. 3, p. 532, doi. 10.1007/s10600-023-04043-2
- By:
- Publication type:
- Article
Mechanisms of Secondary Leukemia Development Caused by Treatment with DNA Topoisomerase Inhibitors.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 7, p. 892, doi. 10.1134/S0006297923070040
- By:
- Publication type:
- Article
Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl.
- Published in:
- Environmental Toxicology, 2015, v. 30, n. 7, p. 803, doi. 10.1002/tox.21959
- By:
- Publication type:
- Article
Surface enhanced Raman spectroscopy as a novel tool for rapid quantification of heroin and metabolites in saliva.
- Published in:
- Turkish Journal of Medical Sciences, 2020, v. 50, n. 5, p. 1470, doi. 10.3906/sag-1912-196
- By:
- Publication type:
- Article
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 1, p. 111, doi. 10.1007/s40487-022-00215-2
- By:
- Publication type:
- Article
INVESTIGATION OF PROTECTIVE EFFECTS OF FULLERENOL in vivo IN CHRONIC NEPHROPATHY DURING DOXORUBICIN THERAPY OF MALIGN NEOPLASM IN RATS.
- Published in:
- Oxidation Communications, 2024, v. 47, n. 1, p. 10
- By:
- Publication type:
- Article
The preventive effects of diosmin alone or combined with irinotecan on 1,2-dimethylhydrazine-induced colon cancer in rats.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 14, p. 4003
- By:
- Publication type:
- Article
Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 14, p. 6605
- By:
- Publication type:
- Article
Curcumin protects against testis-specific side effects of irinotecan.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 23, p. 7440
- By:
- Publication type:
- Article
MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2019, v. 23, n. 20, p. 8861
- By:
- Publication type:
- Article
Using 5-fluorouracil-encored plga nanoparticles for the treatment of colorectal cancer: the in-vitro characterization and cytotoxicity studies.
- Published in:
- Nanomedicine Journal, 2020, v. 7, n. 3, p. 211, doi. 10.22038/nmj.2020.07.0005
- By:
- Publication type:
- Article
The effects Metformin/Irinotecan-loaded PLGA nanoparticles on glutamate re-uptake time and alteration EAAT1 gene expression level in vitro.
- Published in:
- Nanomedicine Journal, 2019, v. 6, n. 1, p. 35, doi. 10.22038/nmj.2019.06.005
- By:
- Publication type:
- Article
Encapsulation of irinotecan in polymeric nanoparticles: Characterization, release kinetic and cytotoxicity evaluation.
- Published in:
- Nanomedicine Journal, 2016, v. 3, n. 3, p. 159, doi. 10.7508/nmj.2016.03.003
- By:
- Publication type:
- Article
Comparative physiological and biochemical evaluation of salt and nickel tolerance mechanisms in two contrasting tomato genotypes.
- Published in:
- Physiologia Plantarum, 2020, v. 168, n. 1, p. 27, doi. 10.1111/ppl.12930
- By:
- Publication type:
- Article
In Silico Study of Camptothecin-Based Pro-Drugs Binding to Human Carboxylesterase 2.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 153, doi. 10.3390/biom14020153
- By:
- Publication type:
- Article
Novel Set of Diarylmethanes to Target Colorectal Cancer: Synthesis, In Vitro and In Silico Studies.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 1, p. 54, doi. 10.3390/biom13010054
- By:
- Publication type:
- Article
Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1256, doi. 10.3390/biom12091256
- By:
- Publication type:
- Article
Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070878
- By:
- Publication type:
- Article
FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c‐Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.881
- By:
- Publication type:
- Article
Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.813
- By:
- Publication type:
- Article
C20orf24 promotes colorectal cancer progression by recruiting Rin1 to activate Rab5‐mediated mitogen‑activated protein kinase/extracellular signal‐regulated kinase signalling.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.796
- By:
- Publication type:
- Article
FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 3, p. 1, doi. 10.1002/ctm2.772
- By:
- Publication type:
- Article
Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.564
- By:
- Publication type:
- Article
Prevotella contributes to individual response of FOLFOX in colon cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 9, p. 1, doi. 10.1002/ctm2.512
- By:
- Publication type:
- Article
Transfer of metastatic traits via miR‐200c in extracellular vesicles derived from colorectal cancer stem cells is inhibited by atractylenolide I.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 4, p. 1, doi. 10.1002/ctm2.139
- By:
- Publication type:
- Article
Passage of irinotecan and its active metabolite, SN-38, into human milk.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 5, p. 579, doi. 10.1111/jcpt.12428
- By:
- Publication type:
- Article
Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1072943
- By:
- Publication type:
- Article
Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer .
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1138357
- By:
- Publication type:
- Article
Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1082771
- By:
- Publication type:
- Article
Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1133689
- By:
- Publication type:
- Article
Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1009484
- By:
- Publication type:
- Article
DNA Methylation Biomarkers Predict Objective Responses to PD-1/PD-L1 Inhibition Blockade.
- Published in:
- Frontiers in Genetics, 2019, p. 1, doi. 10.3389/fgene.2019.00724
- By:
- Publication type:
- Article
Germline Testing, Molecular Profiling Now Recommended in NCCN Pancreatic Cancer Guideline.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 5, p. 195
- By:
- Publication type:
- Article